Expanded criteria for liver transplantation in patients with hepatocellular carcinoma

被引:16
作者
Yao, Francis Y. [1 ]
机构
[1] Univ Calif San Francisco, Dept Clin Med & Surg, San Francisco, CA 94143 USA
关键词
hepatocellular carcinoma; Milan criteria; orthotopic liver transplantation; University of California San; Francisco criteria;
D O I
10.1111/j.1872-034X.2007.00195.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Following the seminal publication by the group from Milan, Italy using a restrictive set of criteria for orthotopic liver transplantation in patients with hepatocellular carcinoma to limit the risk for tumor recurrence, excellent 5-year patient survival of greater than 70% after liver transplantation has been reported from many centers using criteria similar to or slightly exceeding the Milan criteria (single lesion of >= 5 cm, or 2-3 lesions of : 3 cm). The growing experience and success of orthotopic liver transplantation for HCC have also fueled controversies related to expansion of conventional criteria for cadaveric or living-donor liver transplantation based on tumor size and number. The limitations of imaging studies, exemplified by tumor under-staging in up to 25% of patients, have been a major concern for liberalizing the current criteria for liver transplantation. The University of California, San Francisco criteria (single lesion of <= 6.5 cm, or 2-3 lesions of <= 4.5 cm with a total tumor diameter ! 8 cm) have been independently tested in several studies, and undergone prospective evaluation based on preoperative imaging. This article provides an in-depth review of published data on expansion of current criteria for liver transplantation.
引用
收藏
页码:S267 / S274
页数:8
相关论文
共 31 条
[11]   Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation? No, never [J].
Hiatt, JR ;
Carmody, IC ;
Busuttil, RW .
JOURNAL OF HEPATOLOGY, 2005, 43 (04) :573-577
[12]   Liver transplantation for adult patients with hepatocellular carcinoma in Korea: Comparison between cadaveric donor and living donor liver transplantations [J].
Hwang, S ;
Lee, SG ;
Joh, JW ;
Suh, KS ;
Kim, DG .
LIVER TRANSPLANTATION, 2005, 11 (10) :1265-1272
[13]   Living donor liver transplantation for hepatocellular carcinoma [J].
Kulik, L ;
Abecassis, M .
GASTROENTEROLOGY, 2004, 127 (05) :S277-S282
[14]  
Kulik LM, 2005, HEPATOLOGY, V42, p199A
[15]   Liver transplantation outcomes for early-stage hepatocellular carcinoma: Results of a multicenter study [J].
Leung, JY ;
Zhu, AX ;
Gordon, FD ;
Pratt, DS ;
Mithoefer, A ;
Garrigan, K ;
Terella, A ;
Hertl, M ;
Cosimi, AB ;
Chung, RT .
LIVER TRANSPLANTATION, 2004, 10 (11) :1343-1354
[16]   The role and limitation of living donor liver transplantation for hepatocellular carcinoma [J].
Lo, CM ;
Fan, ST ;
Liu, CL ;
Chan, SC ;
Wong, J .
LIVER TRANSPLANTATION, 2004, 10 (03) :440-447
[17]   Liver organ allocation for hepatocellular carcinoma: Are we sure? [J].
Marsh, JW ;
Dvorchik, I .
LIVER TRANSPLANTATION, 2003, 9 (07) :693-696
[18]   Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis [J].
Mazzaferro, V ;
Regalia, E ;
Doci, R ;
Andreola, S ;
Pulvirenti, A ;
Bozzetti, F ;
Montalto, F ;
Ammatuna, M ;
Morabito, A ;
Gennari, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :693-699
[19]   TRANSECTION OF ESOPHAGUS FOR BLEEDING ESOPHAGEAL VARICES [J].
PUGH, RNH ;
MURRAYLY.IM ;
DAWSON, JL ;
PIETRONI, MC ;
WILLIAMS, R .
BRITISH JOURNAL OF SURGERY, 1973, 60 (08) :646-649
[20]   Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters [J].
Roayaie, S ;
Frischer, JS ;
Emre, SH ;
Fishbein, TM ;
Sheiner, PA ;
Sung, M ;
Miller, CM ;
Schwartz, ME .
ANNALS OF SURGERY, 2002, 235 (04) :533-539